Company profile
株式会社アデランスバイオ
This page aggregates company identity, Official Gazette notices, enforcement records, related-company signals, and source-review links into one public-record profile.
RegBase Evidence Report
Company identity, confirmed enforcement records, Official Gazette notices, and source-review fields for internal due-diligence files.
| Display name | 株式会社アデランスバイオ | Original name | 株式会社アデランスバイオ |
|---|---|---|---|
| Corporate Number | Not recorded | Status | Unknown |
| Confirmed enforcement | 0 record(s) | Official Gazette | 1 notice(s) |
| Registry changes | 0 item(s) | Related companies | 0 candidate(s) |
| Latest public record | 19 Jun 2024 | ||
This report summarizes public-source records collected by RegBase. It is not a credit opinion, sanctions result, legal conclusion, or procurement approval. Verify material findings against the linked original Japanese source before relying on them.
| English display | 株式会社アデランスバイオ (Japanese original) |
|---|---|
| Japanese name | 株式会社アデランスバイオ |
| Address | 佐賀県佐賀市卸本町7番40号 |
| Representative | Not recorded |
| Industry | Not recorded |
| Official website | Not recorded |
| Target URL | https://regbase.jp/en/company/9dcd6736-6a1c-4359-bdef-700b5ba8821b |
|---|---|
| Regulatory enforcement disclosures | No confirmed linked record in RegBase monitored coverage |
| Official Gazette notices | 1 notice(s) linked in RegBase coverage |
| Registry-source timestamps | Corporate Number site: 10 Jul 2026 / gBizINFO: 10 Jul 2026 / EDINET: not recorded |
No confirmed enforcement record is currently linked to this company in RegBase monitored sources.
| Citation | 19 Jun 2024 Extra Edition 第147号 p.82 |
|---|---|
| Published name | 株式会社アデランスバイオ |
| Address / court | 和6年6月19日水曜日 官 報 （号 外） 公 告 会社その他の公告 第3期決算公告 令和6年5月 27 日佐賀県佐賀市卸本町7番40号 |
| Excerpt | This is a financial statements notice for the third fiscal period, published on June 19, 2024, showing assets, liabilities, and shareholders' equity as of February 29, Reiwa 6. |
| Original sources checked | |
|---|---|
| Reviewer / date | |
| Internal notes |
Current page: Company profile
This page brings together Official Gazette notices, enforcement records, registry data, related-company signals, and source-review links for one company. Open individual enforcement records from the history section below.
Free report
Includes company identity, enforcement history, Official Gazette notices, source-review fields, and reviewer notes for internal due-diligence files.
Related tool Kiroku
Open Kiroku monitoring and enter the official website, terms, IR, pricing, or announcement URL you want to track.
You do not need this for normal browsing. Use it when integrating this company record into an internal tool or AI workflow.
Note: Detailed gBizINFO registry data may not be available for this company yet. Use the public registry links below to review supplemental source information.
Official Gazette
Adelance Bio Co., Ltd. Financial Statements Notice for the 3rd Term (as of Feb 29, Reiwa 6)
Financial statements noticeFinancial report号外第 １４７ 号 令和６年６月１９日水曜日 官 報 （号 外） 公 告 会社その他の公告page="0082"page="0082" 第３期決算公告 令和６年５月 27 日佐賀県佐賀市卸本町７番40号株式会社アデランスバイオ代表取締役社長 泉本 正明page="0082"貸借対照表の要旨 (令和６年２月29日現在)科 目金 額(千円)資産の部流動資産13,922固定資産32,857 資産合計 46,779 負債及び 純資産の部 流動負債3,950固定負債80,000株主資本△37,171資本金10,000利益剰余金△47,171その他利益剰余金△47,171(うち当期純損失)(18,773)負債・純資産合計46,779©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.
No enforcement records are currently listed in RegBase's monitored sources.
RegBase automatically collects public disclosures from Japanese government sources. Non-public administrative guidance, oral warnings, and unpublished actions are not included. See data sources.
About this English name
No official English name source is recorded. The original Japanese name is shown.
If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.
This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.